• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Selskabsmeddelelse

New Nordic Healthbrands AB (publ) part ways with Chief Commercial and Operating Officer

New Nordic Healthbrands
Download udgivelse

We have today decided to part ways with Chief Commercial and Operating Officer Mr. Tage Juhl Finninge. Tage and CEO Karl Kristian Bergman Jensen both had faith in being able to develop New Nordic together. Unfortunately, the collaboration showed over time that Tage and Karl Kristian's approach to business are too different for an effective teamwork and decision-making and therefore the collaboration had to end.

As of today, CFO, Ivan Ruscic and Karl Kristian will form the Executive Management Team at NEW NORDIC.

We will not search for another CCO or COO in the near future.

Karl Kristian Bergman Jensen, CEO
New Nordic Healthbrands AB

Malmö 29 September 2023

Link to New Nordic's investor relation web page: https://newnordicinvestor.com 

Contact:

Karl Kristian Bergman Jensen, CEO, telephone +46 40-236414, e-mail kk@newnordic.com.
Ivan Ruscic, CFO, telephone +46 40-236414, e-mail ivan@newnordic.se
Claes Libell, Group Financial Controller and Investor Relations, telephone +46 40-236414, e-mail claes@newnordic.se 

New Nordic Healthbrands AB (publ), SE-215 32  Malmö, Sweden. Org. nr. 556698-0453.

Certified advisor: Mangold Fondkommission AB. +46 8 503 01 550, ca@mangold.se 

New Nordic Healthbrands AB (publ) was founded in 1990 and is listed on Nasdaq First North Growth Market Sweden since 2007. The company's business concept is to offer the most effective and safe dietary supplements, natural medicines and cosmetic products for specific health and beauty needs. All with care for people and nature. New Nordic products are now available in 41 countries in pharmacies, health stores, beauty shops, and travel retail. New Nordic has its own small sales and marketing companies in most European countries, Canada and the United States, Hong Kong and Australia, to organise local marketing campaigns, serve retailers and serve end customers. In 2022, revenues were SEK 488 million. Almost all New Nordic products sold worldwide are manufactured in Scandinavia. For more information, visit www.newnordic.com 

Attached files

New_Nordic_Pressrelease_2023-09-29.pdf